Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersPediatric Hematology & Oncology Physician in Little Rock, AR
NPI: 1003089590Primary Practice Location
ARKANSAS CHILDREN'S HOSPITAL
1 Childrens Way, Little Rock, AR
Primary Employer
Childrens University Medical Group
archildrens.org
HQ Phone
Get M.D. Michael's Phone Numberphone_androidMobile
Get M.D. Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAR State Medical License
OH State Medical License
TN State Medical License
AR State Medical License
2024 - 2025
TN State Medical License
2017 - 2025
OH State Medical License
2009 - 2013
MO State Medical License
2006 - 2009
American Board of Pediatrics
Pediatric Hematology-Oncology
American Board of Pediatrics
Pediatrics
Cincinnati Children's Hospital Medical Center
Fellowship • Pediatric Hematology/Oncology
2009 - 2012
Children’s Mercy Hospital
Residency • Pediatrics
2006 - 2009
University of Arkansas For Medical Sciences College of Medicine
Medical School
Until 2006
University of Cincinnati
Masters • Clinical/Translational Research
2010 - 2012
F-FDG PET/CT in the Management of Osteosarcoma.
Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee.
Authors: Richard Gorlick, Arthur Provisor, Paul Meyers, Alexander Chou, Neyssa Marina, Cindy Schwartz, Mark Gebhardt
Publication Date: 2016-04
Neurocognitive and Patient-Reported Outcomes in Adult Survivors of Childhood Osteosarcoma
Authors: Edelmann, Michelle N, Daryani, Vinay M, Bishop, Michael W, Liu, Wei, Brinkman, Tara M, Stewart, Clinton F, Mulrooney, Daniel A, Kimberg, Cara, Ness, Kirsten K, Cheung, Yin Ting, Srivastava, Deo Kumar, Robison, Leslie L, Hudson, Melissa M, Krull, Kevin R
Journal: JAMA Oncol
Lead Sponsor: St. Jude Children's Research Hospital
Collaborators: Pfizer, Gateway for Cancer Research
Intervention / Treatment: DRUG: Avelumab, OTHER: Questionnaires
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Adavosertib, DRUG: Irinotecan Hydrochloride
Lead Sponsor: Eli Lilly and Company
Collaborators: New Approaches to Neuroblastoma Therapy Consortium (NANT), Innovative Therapies for Children with Cancer in Europe (ITCC)
Intervention / Treatment: DRUG: Cyclophosphamide, DRUG: Topotecan, DRUG: LY3295668 Erbumine
